DBV Technologies (DBVT) Return on Assets (2021 - 2026)
DBV Technologies (DBVT) posted quarterly Return on Assets of 0.01% for Q2 2026, up 1.0% year-on-year from 0.01% in Q2 2025, and down 7.33% on a QoQ basis from 0.01% in Q1 2026.
DBV Technologies (DBVT) Return on Assets (2021 - 2026) Analysis & Trends
DBV Technologies (DBVT) has reported Return on Assets for 6 consecutive years, with 0.01% the latest figure, recorded in Q2 2026.
- Quarterly Return on Assets rose 1.0% year-over-year to 0.01% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.01% (up 1.0% YoY) and the FY2025 annual result came in at 0.01%, changed 0.0% from the prior year.
- Return on Assets fell to 0.01% in Q2 2026 per DBVT's latest filing, from 0.01% in the prior quarter.
- Over the last five years, Return on Assets for DBVT reached as high as 0.0% in Q3 2022 and fell as low as 0.02% in Q1 2025.
- A 5-year average of 0.01% and a median of 0.01% in 2026 frame the typical range for Return on Assets.
- Annual changes were most pronounced in 2024 — Return on Assets dropped 1 bps — and 2025, when it advanced 1 bps.
- Year by year, Return on Assets stood at 0.0% in 2022, then decreased by 0 bps to 0.0% in 2023, then plunged by 268 bps to 0.01% in 2024, then surged by 41 bps to 0.01% in 2025, then grew by 16 bps to 0.01% in 2026.
- According to Business Quant data, Return on Assets over the past three periods registered 0.01%, 0.01%, and 0.01% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.69% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.01% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -0.80% |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 0.00% |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.01% |
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | -0.02% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | -0.01% |